0001127602-23-008724.txt : 20230303
0001127602-23-008724.hdr.sgml : 20230303
20230303163238
ACCESSION NUMBER: 0001127602-23-008724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZERBE ROBERT L MD
CENTRAL INDEX KEY: 0001220363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 23704690
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-03-01
0000887359
Vericel Corp
VCEL
0001220363
ZERBE ROBERT L MD
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
1
Common Stock
2023-03-01
4
M
0
3000
10.60
A
34795
D
Stock Option
(Right to Buy)
10.60
2023-03-01
4
M
0
3000
0
D
2023-05-02
Common Stock
3000
0
D
These options, representing the right to purchase a total of 3,000 shares, were originally granted on May 2, 2013, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
/s/ Dominick C. Colangelo, Attorney-in-Fact for Robert Zerbe
2023-03-03